IMN || Infectious Diseases

Best HCV value? Screen all baby boomers, treat all infections

Posted on: 13/11/2014 - 17:12

BOSTON – Screening all adults born between 1945 and 1965 for hepatitis C and then treating all infected patients with oral drug regimens is the most cost effective strategy for society, because...

Field of Interest: Gastroentero...

Type: News Item

Interferon-free regimen benefits HCV-infected liver transplant recipients

Posted on: 11/11/2014 - 14:00

An oral, interferon-free drug regimen produced a 97% rate of sustained virologic response in liver transplant recipients who had recurrent hepatitis C viral infection – “an historically...

Field of Interest: Gastroentero...

Type: News Item

Drug combination successful in hepatitis C plus HIV

Posted on: 10/11/2014 - 16:46

BOSTON – Treating hepatitis C with a combination of ledipasvir and sofosbuvir produced a sustained virologic response in 49 of 50 patients coinfected with genotype 1 hepatitis C and HIV...

Field of Interest: Gastroentero...

Type: News Item

Sofosbuvir-containing regimens dominate hepatitis C treatment

Posted on: 10/11/2014 - 15:49

BOSTON – Since their approval in late 2013, the direct-acting antiviral agents sofosbuvir and simeprevir have taken over treatment of hepatitis C with real-world success that approximates clinical...

Field of Interest: Gastroentero...

Type: News Item

Achieving sustained response key to successful HCV treatment

Posted on: 10/11/2014 - 14:05

BOSTON – Risks for mortality, hepatocellular carcinoma, and liver transplantations were significantly lower in patients with hepatitis C who achieved a sustained virologic response after treatment,...

Field of Interest: Gastroentero...

Type: News Item

ABT-450 combo achieves high SVR12 in hepatitis C

Posted on: 10/11/2014 - 00:00

FROM THE LIVER MEETING 2014A combined formula of ABT-450 with ritonavir, ombitasvir, and dasabuvir, given with ribavirin, yielded high rates of sustained viral response at 12 weeks among...

Field of Interest: Gastroentero...

Type: News Item

Viral suppression of HCV yielded improvements in neural health

Posted on: 10/11/2014 - 00:00

Viral suppression of hepatitis C virus–infected patients improved neural health as measured by magnetic resonance spectroscopy, according to findings from a new study. Treatment led to an increase...

Field of Interest: Gastroentero...

Type: News Item

Sofosbuvir plus GS-5816 yielded high SVR rates in genotype 3 HCV patients

Posted on: 10/11/2014 - 00:00

Sofosbuvir plus GS-5816 yielded high SVR rates in genotype 3 HCV patientsvitalsKey clinical point: Sofosbuvir plus GS-5816 was well tolerated and achieved high SVR rates among...

Field of Interest: Gastroentero...

Type: News Item

Sofosbuvir/ledipasvir improved patient-reported outcomes in HCV

Posted on: 10/11/2014 - 00:00

BOSTON - A hepatitis C treatment regimen of sofosbuvir and ledipasvir without ribavirin is associated with significant improvement in patient-reported outcomes, new research suggests.<br...

Field of Interest: Gastroentero...

Type: News Item

VIDEO: Hepatitis C burden could wallop Medicare

Posted on: 09/11/2014 - 22:27

BOSTON – The graying of America will add at least 1 million more patients with chronic hepatitis C virus infection into the Medicare system between 2010 and 2024. “If all of these patients were...

Field of Interest: Gastroentero...

Type: News Item

« first
‹ previous
1
2
3
4
5
6
7
8
9
…
next ›
last »

Newsletters

Stay informed on our latest news!

You are here

Newsletters

Latest Newsletters